These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20072867)

  • 1. Refractory Kawasaki disease: infliximab or methotrexate therapy?
    Shin JI; Lee JS; Choi JY; Kim DS; Girish M; Subramaniam
    Indian J Pediatr; 2009 Nov; 76(11):1184; author reply 1184. PubMed ID: 20072867
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of infliximab in long-lasting refractory Kawasaki disease.
    Zulian F; Zanon G; Martini G; Mescoli G; Milanesi O
    Clin Exp Rheumatol; 2006; 24(4):453. PubMed ID: 16956440
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab treatment for pediatric refractory Kawasaki disease.
    Blaisdell LL; Hayman JA; Moran AM
    Pediatr Cardiol; 2011 Oct; 32(7):1023-7. PubMed ID: 21773835
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
    Raman V; Kim J; Sharkey A; Chatila T
    Pediatr Infect Dis J; 2001 Jun; 20(6):635-7. PubMed ID: 11419513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab treatment in refractory Kawasaki syndrome.
    Girish M; Subramaniam G
    Indian J Pediatr; 2008 May; 75(5):521-2. PubMed ID: 18537019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory Kawasaki disease.
    Freeman AF; Shulman ST
    Pediatr Infect Dis J; 2004 May; 23(5):463-4. PubMed ID: 15131473
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH; Liu PM; Bong CN; Wu YT; Yang KD; Wang CL
    J Microbiol Immunol Infect; 2005 Apr; 38(2):149-52. PubMed ID: 15843862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
    Son MB; Gauvreau K; Burns JC; Corinaldesi E; Tremoulet AH; Watson VE; Baker A; Fulton DR; Sundel RP; Newburger JW
    J Pediatr; 2011 Apr; 158(4):644-649.e1. PubMed ID: 21129756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
    O'connor MJ; Saulsbury FT
    Clin Pediatr (Phila); 2007 May; 46(4):345-8. PubMed ID: 17475994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for Kawasaki syndrome.
    Saji T; Kemmotsu Y
    J Pediatr; 2006 Sep; 149(3):426; author reply 426. PubMed ID: 16939768
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophage activation syndrome in Kawasaki disease.
    Mukherjee D; Pal P; Kundu R; Niyogi P
    Indian Pediatr; 2014 Feb; 51(2):148-9. PubMed ID: 24632699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of refractory Kawasaki disease to intravenous methylprednisolone.
    Shah I; Prabhu SS
    Ann Trop Paediatr; 2009 Mar; 29(1):51-3. PubMed ID: 19222935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
    Chan H; Chi H; You H; Wang M; Zhang G; Yang H; Li Q
    BMC Pediatr; 2019 May; 19(1):158. PubMed ID: 31101091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of refractory kawasaki disease.
    Ng SH; Roshan S
    Med J Malaysia; 2018 Dec; 73(6):410-412. PubMed ID: 30647216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of corticosteroid therapy in refractory Kawasaki patients.
    Al-Mayouf SM
    Clin Rheumatol; 2004 Feb; 23(1):11-3. PubMed ID: 14749974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review.
    Crayne CB; Mitchell C; Beukelman T
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):77. PubMed ID: 31775898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory pneumonia and high fever.
    Falcini F; Vitale A; La Torre F; Conti G; Fede C; Calcagno G
    Lancet; 2009 May; 373(9677):1818. PubMed ID: 19465237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.